Catalyst Wire Dossier Catalyst Wire Dossier

XR-Naltrexone

naltrexone
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for XR-Naltrexone, covering 2020-10-05 to 2020-10-05. Get the full timeline:

Most recent: Clinical Trial Update: Lorcaserin in Combination With XR-Naltrexone for Relapse Prevention in Opioid Use Disorder [Phase 2, Phase 3]

See pricing